company background image
POLYMED logo

Poly Medicure NSEI:POLYMED Rapporto sulle azioni

Ultimo prezzo

₹2.61k

Cap. di mercato

₹263.8b

7D

-3.8%

1Y

71.7%

Aggiornato

19 Nov, 2024

Dati

Dati finanziari dell'azienda +

Poly Medicure Limited

NSEI:POLYMED Rapporto sulle azioni

Cap. di mercato: ₹263.8b

POLYMED Panoramica delle azioni

Poly Medicure Limited produce e vende dispositivi medici in India e a livello internazionale. Maggiori dettagli

POLYMED analisi fondamentale
Punteggio fiocco di neve
Valutazione0/6
Crescita futura4/6
Prestazioni passate4/6
Salute finanziaria6/6
Dividendi0/6

Premi

Si prevede che gli utili cresceranno del 23.55% all'anno

Gli utili sono cresciuti del 26.2% nell'ultimo anno

Analisi del rischio

Elevato livello di guadagni non monetari

Gli azionisti sono stati diluiti nell'ultimo anno


Poly Medicure Limited Concorrenti

Prevest Denpro

BSE:543363

₹6.5b

Narayana Hrudayalaya

NSEI:NH

₹256.3b

Krishna Institute of Medical Sciences

NSEI:KIMS

₹227.0b

Dr. Lal PathLabs

NSEI:LALPATHLAB

₹253.4b

Storia dei prezzi e prestazioni

Riepilogo dei massimi storici, delle variazioni e dei cali di prezzo di tutti i tempi per Poly Medicure
Prezzi storici delle azioni
Prezzo attuale dell'azione₹2,607.70
Massimo di 52 settimane₹3,357.80
Minimo di 52 settimane₹1,361.00
Beta0.34
1Variazione di 1 mese6.33%
Variazione a 3 mesi19.45%
Variazione di 1 anno71.67%
3Variazione a 3 anni173.47%
Variazione a 5 anni1,160.37%
Variazione dall'IPO7,162.52%

Notizie e aggiornamenti recenti

Why Investors Shouldn't Be Surprised By Poly Medicure Limited's (NSE:POLYMED) 33% Share Price Surge

Nov 02
Why Investors Shouldn't Be Surprised By Poly Medicure Limited's (NSE:POLYMED) 33% Share Price Surge

Recent updates

Why Investors Shouldn't Be Surprised By Poly Medicure Limited's (NSE:POLYMED) 33% Share Price Surge

Nov 02
Why Investors Shouldn't Be Surprised By Poly Medicure Limited's (NSE:POLYMED) 33% Share Price Surge

Shareholders Will Probably Hold Off On Increasing Poly Medicure Limited's (NSE:POLYMED) CEO Compensation For The Time Being

Sep 20
Shareholders Will Probably Hold Off On Increasing Poly Medicure Limited's (NSE:POLYMED) CEO Compensation For The Time Being

Poly Medicure (NSE:POLYMED) Will Pay A Dividend Of ₹3.00

Sep 14
Poly Medicure (NSE:POLYMED) Will Pay A Dividend Of ₹3.00

After Leaping 41% Poly Medicure Limited (NSE:POLYMED) Shares Are Not Flying Under The Radar

Sep 06
After Leaping 41% Poly Medicure Limited (NSE:POLYMED) Shares Are Not Flying Under The Radar

Poly Medicure (NSE:POLYMED) Has A Pretty Healthy Balance Sheet

Aug 14
Poly Medicure (NSE:POLYMED) Has A Pretty Healthy Balance Sheet

Earnings Update: Here's Why Analysts Just Lifted Their Poly Medicure Limited (NSE:POLYMED) Price Target To ₹2,138

Jul 27
Earnings Update: Here's Why Analysts Just Lifted Their Poly Medicure Limited (NSE:POLYMED) Price Target To ₹2,138

Investors Still Waiting For A Pull Back In Poly Medicure Limited (NSE:POLYMED)

Jul 11
Investors Still Waiting For A Pull Back In Poly Medicure Limited (NSE:POLYMED)

Poly Medicure's (NSE:POLYMED) Promising Earnings May Rest On Soft Foundations

May 25
Poly Medicure's (NSE:POLYMED) Promising Earnings May Rest On Soft Foundations

Why You Should Care About Poly Medicure's (NSE:POLYMED) Strong Returns On Capital

May 12
Why You Should Care About Poly Medicure's (NSE:POLYMED) Strong Returns On Capital

Poly Medicure Limited's (NSE:POLYMED) Share Price Not Quite Adding Up

Mar 23
Poly Medicure Limited's (NSE:POLYMED) Share Price Not Quite Adding Up

Here's Why We Think Poly Medicure (NSE:POLYMED) Might Deserve Your Attention Today

Feb 15
Here's Why We Think Poly Medicure (NSE:POLYMED) Might Deserve Your Attention Today

Poly Medicure (NSE:POLYMED) Seems To Use Debt Quite Sensibly

Jan 16
Poly Medicure (NSE:POLYMED) Seems To Use Debt Quite Sensibly

Is Now The Time To Put Poly Medicure (NSE:POLYMED) On Your Watchlist?

Nov 14
Is Now The Time To Put Poly Medicure (NSE:POLYMED) On Your Watchlist?

Poly Medicure (NSE:POLYMED) Has More To Do To Multiply In Value Going Forward

Oct 24
Poly Medicure (NSE:POLYMED) Has More To Do To Multiply In Value Going Forward

Shareholders Will Probably Hold Off On Increasing Poly Medicure Limited's (NSE:POLYMED) CEO Compensation For The Time Being

Sep 22
Shareholders Will Probably Hold Off On Increasing Poly Medicure Limited's (NSE:POLYMED) CEO Compensation For The Time Being

Poly Medicure (NSE:POLYMED) Is Increasing Its Dividend To ₹3.00

Sep 08
Poly Medicure (NSE:POLYMED) Is Increasing Its Dividend To ₹3.00

Here's Why Poly Medicure (NSE:POLYMED) Can Manage Its Debt Responsibly

Aug 12
Here's Why Poly Medicure (NSE:POLYMED) Can Manage Its Debt Responsibly

Here's Why We Think Poly Medicure (NSE:POLYMED) Is Well Worth Watching

Jul 13
Here's Why We Think Poly Medicure (NSE:POLYMED) Is Well Worth Watching

Poly Medicure (NSE:POLYMED) Is Reinvesting At Lower Rates Of Return

Jun 16
Poly Medicure (NSE:POLYMED) Is Reinvesting At Lower Rates Of Return

Be Wary Of Poly Medicure (NSE:POLYMED) And Its Returns On Capital

Mar 02
Be Wary Of Poly Medicure (NSE:POLYMED) And Its Returns On Capital

We Think Poly Medicure (NSE:POLYMED) Can Stay On Top Of Its Debt

Feb 14
We Think Poly Medicure (NSE:POLYMED) Can Stay On Top Of Its Debt

Capital Allocation Trends At Poly Medicure (NSE:POLYMED) Aren't Ideal

Oct 16
Capital Allocation Trends At Poly Medicure (NSE:POLYMED) Aren't Ideal

We Think Poly Medicure (NSE:POLYMED) Can Stay On Top Of Its Debt

Sep 28
We Think Poly Medicure (NSE:POLYMED) Can Stay On Top Of Its Debt

Poly Medicure (NSE:POLYMED) Has Affirmed Its Dividend Of ₹2.50

Sep 08
Poly Medicure (NSE:POLYMED) Has Affirmed Its Dividend Of ₹2.50

Here's Why Poly Medicure (NSE:POLYMED) Can Manage Its Debt Responsibly

Jun 25
Here's Why Poly Medicure (NSE:POLYMED) Can Manage Its Debt Responsibly

A Look At The Intrinsic Value Of Poly Medicure Limited (NSE:POLYMED)

Jun 07
A Look At The Intrinsic Value Of Poly Medicure Limited (NSE:POLYMED)

Poly Medicure (NSE:POLYMED) Will Want To Turn Around Its Return Trends

May 23
Poly Medicure (NSE:POLYMED) Will Want To Turn Around Its Return Trends

With EPS Growth And More, Poly Medicure (NSE:POLYMED) Is Interesting

Feb 23
With EPS Growth And More, Poly Medicure (NSE:POLYMED) Is Interesting

There Are Reasons To Feel Uneasy About Poly Medicure's (NSE:POLYMED) Returns On Capital

Feb 04
There Are Reasons To Feel Uneasy About Poly Medicure's (NSE:POLYMED) Returns On Capital

Poly Medicure (NSE:POLYMED) Seems To Use Debt Quite Sensibly

Jan 12
Poly Medicure (NSE:POLYMED) Seems To Use Debt Quite Sensibly

With EPS Growth And More, Poly Medicure (NSE:POLYMED) Is Interesting

Oct 14
With EPS Growth And More, Poly Medicure (NSE:POLYMED) Is Interesting

Poly Medicure (NSE:POLYMED) Could Easily Take On More Debt

Jul 07
Poly Medicure (NSE:POLYMED) Could Easily Take On More Debt

Poly Medicure (NSE:POLYMED) Will Will Want To Turn Around Its Return Trends

Jun 18
Poly Medicure (NSE:POLYMED) Will Will Want To Turn Around Its Return Trends

Poly Medicure's (NSE:POLYMED) Solid Profits Have Weak Fundamentals

May 31
Poly Medicure's (NSE:POLYMED) Solid Profits Have Weak Fundamentals

Earnings Update: Here's Why Analysts Just Lifted Their Poly Medicure Limited (NSE:POLYMED) Price Target To ₹1,195

May 26
Earnings Update: Here's Why Analysts Just Lifted Their Poly Medicure Limited (NSE:POLYMED) Price Target To ₹1,195

Rendimenti per gli azionisti

POLYMEDIN Medical EquipmentIN Mercato
7D-3.8%-3.7%-1.8%
1Y71.7%65.7%27.2%

Ritorno vs Industria: POLYMED ha superato il Indian Medical Equipment che ha restituito 63.5 % nell'ultimo anno.

Rendimento vs Mercato: POLYMED ha superato il mercato Indian che ha restituito 27 % nell'ultimo anno.

Volatilità dei prezzi

Is POLYMED's price volatile compared to industry and market?
POLYMED volatility
POLYMED Average Weekly Movement6.3%
Medical Equipment Industry Average Movement6.7%
Market Average Movement6.2%
10% most volatile stocks in IN Market9.2%
10% least volatile stocks in IN Market4.0%

Prezzo delle azioni stabile: POLYMED non ha avuto una volatilità dei prezzi significativa negli ultimi 3 mesi.

Volatilità nel tempo: La volatilità settimanale ( 6% ) di POLYMED è rimasta stabile nell'ultimo anno.

Informazioni sull'azienda

FondatoI dipendentiAMMINISTRATORE DELEGATOSito web
19956,300Himanshu Baidwww.polymedicure.com

Poly Medicure Limited produce e vende dispositivi medici in India e a livello internazionale. Offre dispositivi per infusione, come cannule per flebo, cateteri mid line, cannule arteriose, rubinetti di arresto a tre vie, set per infusione endovenosa, manifold, set per infusione con ali di sicurezza, set di estensione a T, stiletti/mandrini con luer lock, punte di accesso alle fiale, set per somministrazione di fluidi a volume misurato, linee di estensione, cateteri venosi centrali, manometri CVP, connettori senza ago, siringhe pre-riempite, accessi vascolari e set per la somministrazione di sangue. L'azienda fornisce anche tubi di alimentazione nasogastrica e infantile, tubi di alimentazione gastro-duodenale e cateteri ombelicali; sacche di raccolta dell'urina, cateteri a palloncino foley, set di irrigazione, cateteri di drenaggio dell'urina e sacche di raccolta dell'urina con misuratori di volume; tubi endotracheali e tracheostomici, estrattori di muco, circuiti per ventilatori, circuiti di bagnomaria, supporti per cateteri, aghi spinali, filtri HME e vie aeree a maschera laringea.

Poly Medicure Limited Riepilogo dei fondamenti

Come si confrontano gli utili e i ricavi di Poly Medicure con la sua capitalizzazione di mercato?
POLYMED statistiche fondamentali
Capitalizzazione di mercato₹263.78b
Guadagni(TTM)₹2.95b
Ricavi(TTM)₹15.22b

89.5x

Rapporto P/E

17.3x

Rapporto P/S

POLYMED è sopravvalutato?

Vedi Fair Value e analisi di valutazione

Guadagni e ricavi

Statistiche chiave sulla redditività dall'ultima relazione sugli utili (TTM)
POLYMED Conto economico (TTM)
Ricavi₹15.22b
Costo del fatturato₹5.14b
Profitto lordo₹10.08b
Altre spese₹7.13b
Guadagni₹2.95b

Ultimi guadagni dichiarati

Sep 30, 2024

Prossima data di guadagno

n/a

Utile per azione (EPS)29.10
Margine lordo66.23%
Margine di profitto netto19.37%
Rapporto debito/patrimonio netto6.1%

Come si è comportato POLYMED nel lungo periodo?

Vedi performance storica e confronto

Dividendi

0.1%

Rendimento attuale del dividendo

11%

Rapporto di remunerazione